BBIO position history
The shares of Bridgebio Pharma (BBIO) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 35,649 shares, $1.5M, <0.01% of portfolio, New
- 2025 Q3: 36,164 shares, $1.9M, <0.01% of portfolio, Add +1.4%
- 2025 Q4: 38,241 shares, $2.9M, 0.01% of portfolio, Add +5.7%
- 2026 Q1: 45,934 shares, $3.4M, 0.02% of portfolio, Add +20.1%
- 2026 Q2: 4,002 shares, $298K, <0.01% of portfolio, Reduce −91.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|